Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies. The company offers active pharmaceutical ingredients, human and finished dosage formulations, generics, branded generics, specialty formulations, biosimilars, vaccines, novel therapeutics, medical devices and technologies, consumer wellness, veterinary, and animal health products.
Ver gráficos interactivos y estados completos →
| Cuenta de resultados | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Ingresos totales | ₹267.2B | ₹225.7B | ₹190.2B | ₹168.8B | — |
| Beneficio bruto | ₹190.6B | ₹159.1B | ₹125.2B | ₹103.2B | — |
| Ingresos operativos (EBIT) | ₹57.9B | ₹59.8B | ₹45.4B | ₹28.5B | — |
| Ingresos netos | ₹50.4B | ₹45.3B | ₹38.6B | ₹19.6B | — |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de ZYDUSLIFE. /companies/us/ZYDUSLIFE
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms